Oral Answers to Questions

Debate between Ben Everitt and Matt Hancock

Tuesday 12th January 2021 Commons Chamber

[Matt Hancock]

I am really delighted to highlight that news and I am also glad that, as the hon. Gentleman has just demonstrated, this is a national effort that we can all play our part in. The cross-party support that we and the NHS have received for the vaccination effort is incredibly welcome, and I know that the NHS team on the ground will really appreciate the hon. Gentleman’s support. The kit will be delivered on time—over 98% of vaccines have been delivered on time. Of course, in a very large logistical exercise there is always the occasional hiccup, but I will get back to the hon. Gentleman and make sure that the Minister for covid vaccine deployment, my hon. Friend the Member for Stratford-on-Avon (Nadhim Zahawi), gets back to him with the precise details of when the kit will arrive at his local hospital.

[Ben Everitt]

It is fantastic news that 2.3 million people across the whole of the UK have already received the first dose of this vaccine. Businesses and venues across Milton Keynes are queuing up to offer their support for the vaccination programme, including the wonderful ECG Training, where I went for a covid test last week—I passed by the way, Mr Speaker. Can the Secretary of State tell us what the plan is for accepting these kind offers of help and support with the vaccination programme?

[Matt Hancock]

I am really delighted that ECG Training is involved in hosting some of the testing centres. We have had amazing offers of support in the form of places that are now being used as testing centres and as some of the 1,000-plus vaccination centres across the country. We have been working since the summer with some sites to ensure that they were ready to be vaccination centres. We are always open to further offers of support, but I would say that we have been working on this for some time. It is also important that, for infection control reasons, testing centres and vaccine sites that are put in the same place are kept separate, not least because we want to make sure that when an octogenarian goes for a vaccine, they are kept safe in the process of getting that vaccine. The thing to do is raise this specific offer of support with the Minister responsible for vaccine deployment, my hon. Friend the Member for Stratford-on-Avon.

Covid-19

Debate between Ben Everitt and Matt Hancock

Tuesday 1st September 2020 Commons Chamber

[Matt Hancock]

We have indeed stopped “Shaping a healthier future”, as it was called. We are continuing with the investment into primary healthcare services that was a part of that programme, but not with the rest of it. I am happy to arrange a meeting between the Minister for Health, my hon. Friend the Member for Charnwood, who is brilliant on this stuff, and the hon. Lady and other west London colleagues, to ensure that that commitment is kept to.

[Ben Everitt (Milton Keynes North) (Con)]

I thank the Secretary of State and his Department for the additional funding for Milton Keynes University Hospital of £1.5 million for winter preparedness. May I stress—and hope that he agrees with me—that it is not just about the threat of covid this winter, but the dual threat with the winter flu?

[Matt Hancock]

Yes. Both my colleagues from Milton Keynes have been assiduous in making the case for the need for expansion at Milton Keynes Hospital. The team there have been absolutely brilliant, even while the chief executive has also been stepping up to national responsibilities in response to this crisis. I hope that the expansion of A&E will help to ensure that my hon. Friend’s constituents can access emergency services when they need them.

Covid-19

Debate between Ben Everitt and Matt Hancock

Monday 16th March 2020 Commons Chamber

[Matt Hancock]

Our estimate of the total number of new cases is significantly higher than the available number of tests right now, which is why we need to increase testing capacity so quickly.

[Ben Everitt (Milton Keynes North) (Con)]

Something that will unite us across this House is our utter admiration for the great British public. All parts of our society have responded to this crisis—our public health officials, families, communities and, today, businesses that have heeded the call for ventilator production. Can the Secretary of State confirm that, as well as the hotline, there is now also an email address for businesses to send their response to if they want to contribute to the national ventilator effort?

[Matt Hancock]

Yes, there is. We have been absolutely overwhelmed with the positive response to the national effort for building ventilators. That email address is up and running, and we are trying to engage with everybody who contacts us.

Coronavirus

Debate between Ben Everitt and Matt Hancock

Monday 9th March 2020 Commons Chamber

[Matt Hancock]

Of course trade unions have an important role to play in this as well, and that is something we absolutely should consider.

[Ben Everitt (Milton Keynes North) (Con)]

The Secretary of State is no doubt aware that one of the four deaths that he referred to in his statement was an elderly patient with underlying health conditions in Milton Keynes University Hospital. What steps is he taking to ensure that hospitals like Milton Keynes University Hospital and others are open, safe and clean?

[Matt Hancock]

All of the hospitals that have so far dealt with cases—and, indeed, the four confirmed deaths—have protocols in place to ensure that the hospital remains a safe place to treat everybody else. The evidence so far is that that has worked well, but of course we keep working at it.

Medicines and Medical Devices Bill

Debate between Ben Everitt and Matt Hancock

2nd reading & 2nd reading: House of Commons & Money resolution & Money resolution: House of Commons & Programme motion & Programme motion: House of Commons & Ways and Means resolution & Ways and Means resolution: House of Commons
Monday 2nd March 2020 Commons Chamber

[Matt Hancock]

It is almost as though the hon. Gentleman has read my speech. That is the broad intent of that part of the Bill. I will come to it in more detail in a moment, and I am glad about the constructive tone that has been adopted across the House when discussing the Bill.

As I said, the fourth purpose of the Bill is to get innovation while not compromising patient safety—indeed, I would argue that we will enhance patient safety by being able to use modern techniques. It will do that by requiring the Secretary of State to have regard to the safety of medicines and medical devices; to the availability of medicines and devices, because sometimes getting availability as fast as possible is crucial for both innovation and patient safety; and to the attractiveness of the UK as a place to conduct clinical trials and bring medicines and medical devices to market. I will come on to clinical trials in more detail.

Let me turn to the main parts of the Bill. The first part, covering clauses 1 to 7, gives us the ability to update the law relating to human medicines—for example, to reflect changes in manufacturing methods or new types of product. We need that ability because coming down the track are cutting-edge personalised medicines that a hospital might literally have to assemble at the patient’s bedside. Those include gene therapies, medical gases and 3D-printed tablets—bespoke treatments so tailored to the individual that they will only be produced once, with a shelf life that might be measured in minutes. It is just not appropriate to regulate those kinds of treatment in the same way as a mass-produced factory drug, with mandatory batch numbers and packaging information. The Bill gives us the flexibility to respond to those developments. It also allows us to make changes to the regulation of clinical trials, ensuring that we are a globally attractive market to test new drugs and treatments.

But the Bill is not just about the latest science and innovation. It also means that we can update the rules on things such as labelling requirements—for instance, whether the leaflet in a pill packet should have a digital equivalent; rules on how online pharmacies ensure that medicines reach their intended customer; and rules on how the medicine brokerage market works.

We have said that we want to do more to boost the role of our brilliant community pharmacists, and the Bill helps us to do exactly that. It will allow us to remove the barriers to hub-and-spoke dispensing once EU rules no longer apply. Large companies such as Boots already do that, but the law as it stands prevents small, independent pharmacies from joining this kind of arrangement if the hub is not part of the same retail business as the spokes. That is an unnecessary barrier for smaller businesses in the pharmacy sector, and the Bill means that we can remove those barriers.

It also allows us to continue to add to the range of healthcare professionals who can prescribe medicines, which will relieve pressure on the frontline NHS, and it gives us the ability to make rapid changes to regulations to ensure the availability of and access to medicines in an emergency; I am sure we can all understand right now why that is important. Nothing in the Bill changes all the regulations immediately. Instead, it is about getting ahead of the game and giving us the power to make these changes as and when we need to, suitably scrutinised by Parliament.

The next part of the Bill concerns veterinary medicines. It broadly replicates the first part, giving us the ability to amend or supplement the Veterinary Medicines Regulations 2013. Changes could include, for instance, how veterinary medicines are supplied and the information that must be supplied with them. It sets out that, in making new regulations, we have an obligation to consider the safety of the medicines in relation to animals, humans and the environment. These are important matters, not least for me as the Newmarket MP. The Bill will ensure that we have a veterinary medicine system that is fit for purpose.

The third part of the Bill deals with the medical devices regulatory framework, covering everything from MRI scanners to embolisation coils and pacemakers to prophylactics. Like the first part, it allows us to fast-track a new diagnostic test in response to an emerging disease.

[Ben Everitt (Milton Keynes North) (Con)]

Is this not an example of how, having left the EU, we can now move at a much faster pace on a lot of regulatory things that are really important to our constituents?

[Matt Hancock]

Yes, that is right. This Bill empowers us to be able to move faster. Essentially, it empowers the UK to build a life sciences regulatory framework that is the best in the world—of course, working with EU partners, but also with partners from right around the world—and all with the intention of getting the most innovative products, as quickly as possible and as cost-effectively as possible, into the NHS. That is the goal of the entire Bill. It is a benefit of Brexit, but it is also worth doing in its own right.

The measures to strengthen innovation with respect to diagnostic tests again strengthen patient safety, because they strengthen the role of the Medicines and Healthcare Products Regulatory Agency. This includes, for instance, allowing us to legislate to create a comprehensive statutory register of medical devices in the UK. Such a register could be held by the MHRA, and we would make it compulsory to register a device along with information such as who manufactures and supplies it. This would mean that the MHRA could conduct post-market surveillance of devices in the UK, making it easier to trigger device recalls where a safety concern arises.

Indeed, we will enhance patient safety by giving the MHRA a new power to disclose to members of the public any safety concerns about a device. This was not possible while we were part of the EU. Previously, if an NHS trust raised a concern about a device and asked if similar reports had been received elsewhere, too often the MHRA was restricted in sharing that information; nor could it always routinely share information with the Care Quality Commission or other NHS national bodies. This Bill gives us the ability to share vital information about reporting patterns with the NHS family, and where necessary with the public, with enforcement powers that will be proportionate, transparent and suitably safeguarded.

Coronavirus

Debate between Ben Everitt and Matt Hancock

Wednesday 26th February 2020 Commons Chamber

[Matt Hancock]

It is a very important question. We are getting as much information as we possibly can, through the Foreign Office, to those who are in Tenerife. As I announced in the statement, we will shortly be strengthening our domestic communications programme to ensure that people have all the information they need.

[Ben Everitt (Milton Keynes North) (Con)]

I was very pleased when, yesterday evening, the Health Minister took me aside and said how well the whole of Milton Keynes had reacted to hosting a quarantine centre, and he was right of course. The professionals in the NHS— clinical and managerial—were fantastic, as were the officers in the council. I think we should recognise that the whole health team—the Secretary of State and his Ministers, advisers and officials—and, indeed, parliamentarians on any Bench in this House, have reacted incredibly well to this situation. So can the Secretary of State reassure us that this is part of the UK being the best prepared—or among the very well prepared —in the world to deal with this kind of outbreak?

[Matt Hancock]

My hon. Friend is right about Milton Keynes. The people of Milton Keynes have done exactly the right thing, and I would add to his list Milton Keynes University Hospital, which has done a brilliant job. More broadly, I would also add the media, who have in very large part responded in an incredibly responsible way to a very big story. We have detailed operational plans for dealing with this situation, including if it gets much worse, and those plans are worked on and updated in response to all the information we get, but part of the plan is about the behaviour of people and how people respond in this House and in the country. Thus far we have seen an exemplary response. I hope that continues.

Wuhan Coronavirus

Debate between Ben Everitt and Matt Hancock

Tuesday 11th February 2020 Commons Chamber

[Matt Hancock]

Yes, I do. On isolation, in particular, the two go hand in hand. People can play a part in combating this virus by washing their hands and using tissues and, if they are symptomatic, by calling 111 before going to a doctor and self-isolating when necessary.

[Ben Everitt (Milton Keynes North) (Con)]

I thank the Secretary of State and his team for keeping me and my hon. Friend the Member for Milton Keynes South (Iain Stewart) updated throughout this process. It has been a very worrying time, but that information has been very useful. I am sure the whole House will join me in congratulating the professional way the local healthcare professionals, including those at Milton Keynes hospital and beyond, and our wonderful council officers have risen to the challenge of hosting a coronavirus facility in Milton Keynes. It is also worth mentioning the police, who now have additional powers to keep that site safe. Can the Secretary of State assure me and the people of Milton Keynes that all the appropriate processes, procedures and powers are in place to keep our residents and their families safe?

Wuhan Coronavirus

Debate between Ben Everitt and Matt Hancock

Monday 3rd February 2020 Commons Chamber

[Matt Hancock]

Yes, I would be happy to make that commitment. As the hon. Member may know, I was born and brought up in Chester; the Wirral is but a stone’s throw away. I wish to add Wirral Council to her list. It has done a great job in difficult circumstances, and worked closely with us to ensure the best support for those evacuees currently at Arrowe Park and for everybody on the Wirral, so that they get the support they need.

[Ben Everitt (Milton Keynes North) (Con)]

Can my right hon. Friend point people to a resource where they could look up the symptoms they might have, what symptoms are indicative of the coronavirus and what they might do if they think they are infected?

[Matt Hancock]

The first thing people can do is ring 111, or look on the Public Health England website and the NHS website, which includes links. Critically, people should not go to A& E or to their GP without first calling 111 because they may inadvertently contribute to the spread of the virus, rather than contain it.

NHS Funding Bill

Debate between Ben Everitt and Matt Hancock

2nd reading & 2nd reading: House of Commons
Monday 27th January 2020 Commons Chamber

[Matt Hancock]

I am happy to meet my hon. Friend to discuss the needs of that hospital. It was started as a PFI, but I brought it on to the balance sheet to ensure that we can absolutely deliver it. This shows why people do not trust Mr PFI with the NHS.

[Ben Everitt (Milton Keynes North) (Con)]

I am sure that my right hon. Friend agrees with me on the need for hospital capacity to grow as our growing cities add to their populations. Will he commit to meeting me to discuss how we can bring forward and accelerate the infrastructure improvement plans for Milton Keynes Hospital?

[Matt Hancock]

Yes, I absolutely will. Milton Keynes hospital is extremely well run by fantastic staff. I did a night shift there a few months ago and—this is a really good example—the porters have redesigned their own system to make their job more efficient, and the management absolutely embraced it. It is an example of how good hospitals should be run. Perhaps on this point I can bring my speech to a conclusion—

Health and Social Care

Debate between Ben Everitt and Matt Hancock

Thursday 16th January 2020 Commons Chamber

[Matt Hancock]

I will continue to take some interventions, if the House will allow me, and then make some progress.

[Ben Everitt (Milton Keynes North) (Con)]

The Secretary of State is being very generous in giving way a number of times. I would like to thank him for his visit to Milton Keynes, and for his commitment to investing not only in extra capacity but in infrastructure improvements in our hospitals. Is he aware of the radiology and radiotherapy treatment situation in Milton Keynes, with patients having to travel to Oxford, temporarily, to receive their treatment? That is not the best situation for those patients. Is he aware of the situation?

[Matt Hancock]

I am, because Milton Keynes’s new MP has already been working with me to bring this concern to light. I can inform him that the new cancer unit will be handed over to Milton Keynes hospital at the end of next week. That problem is indeed temporary and it is being resolved, very much thanks to the hard work of the new MP for Milton Keynes.